Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alimuddin Zumla and Simon Tiberi.
Alimuddin Zumla
Connection Strength
4.212
Simon Tiberi
  1. Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S96-S99.
    View in: PubMed
    Score: 0.934
  2. COVID-19 and tuberculosis-threats and opportunities. Int J Tuberc Lung Dis. 2020 08 01; 24(8):757-760.
    View in: PubMed
    Score: 0.895
  3. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect Dis. 2018 07; 18(7):e183-e198.
    View in: PubMed
    Score: 0.760
  4. Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB". Int J Infect Dis. 2018 03; 68:122-124.
    View in: PubMed
    Score: 0.760
  5. World Tuberculosis Day 2021 Theme - 'The Clock is Ticking' - and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic. Int J Infect Dis. 2021 12; 113 Suppl 1:S1-S6.
    View in: PubMed
    Score: 0.234
  6. Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S7-S12.
    View in: PubMed
    Score: 0.233
  7. Accelerating the development of therapeutic strategies for drug-resistant tuberculosis. Nat Rev Drug Discov. 2018 09; 17(9):607-608.
    View in: PubMed
    Score: 0.190
  8. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J. 2020 10; 56(4).
    View in: PubMed
    Score: 0.057
  9. Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials. Am J Trop Med Hyg. 2020 09; 103(3):960-964.
    View in: PubMed
    Score: 0.056
  10. New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis. J Bras Pneumol. 2018 Apr; 44(2):153-160.
    View in: PubMed
    Score: 0.048
  11. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur Respir J. 2017 05; 49(5).
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.